Correlation Between 4D Molecular and Star Equity

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both 4D Molecular and Star Equity at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 4D Molecular and Star Equity into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 4D Molecular Therapeutics and Star Equity Holdings, you can compare the effects of market volatilities on 4D Molecular and Star Equity and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 4D Molecular with a short position of Star Equity. Check out your portfolio center. Please also check ongoing floating volatility patterns of 4D Molecular and Star Equity.

Diversification Opportunities for 4D Molecular and Star Equity

0.62
  Correlation Coefficient

Poor diversification

The 3 months correlation between FDMT and Star is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding 4D Molecular Therapeutics and Star Equity Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Star Equity Holdings and 4D Molecular is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 4D Molecular Therapeutics are associated (or correlated) with Star Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Star Equity Holdings has no effect on the direction of 4D Molecular i.e., 4D Molecular and Star Equity go up and down completely randomly.

Pair Corralation between 4D Molecular and Star Equity

Given the investment horizon of 90 days 4D Molecular Therapeutics is expected to generate 1.09 times more return on investment than Star Equity. However, 4D Molecular is 1.09 times more volatile than Star Equity Holdings. It trades about -0.08 of its potential returns per unit of risk. Star Equity Holdings is currently generating about -0.27 per unit of risk. If you would invest  857.00  in 4D Molecular Therapeutics on August 29, 2024 and sell it today you would lose (70.00) from holding 4D Molecular Therapeutics or give up 8.17% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

4D Molecular Therapeutics  vs.  Star Equity Holdings

 Performance 
       Timeline  
4D Molecular Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days 4D Molecular Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's primary indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Star Equity Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Star Equity Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unsteady performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

4D Molecular and Star Equity Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with 4D Molecular and Star Equity

The main advantage of trading using opposite 4D Molecular and Star Equity positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 4D Molecular position performs unexpectedly, Star Equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Star Equity will offset losses from the drop in Star Equity's long position.
The idea behind 4D Molecular Therapeutics and Star Equity Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Stocks Directory
Find actively traded stocks across global markets
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like